Active Video Game-Based Exercise Training and Stability Training After AIS Surgery
Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Jul 5, 2024
Trial Information
Current as of August 23, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Posterior Spinal Fusion (PSF) is considered the gold standard in the surgical treatment of Adolescent Idiopathic Scoliosis (AIS) as it provides successful results in terms of deformity correction. However, it has been emphasized in many studies that postoperative rehabilitation should be planned to reduce pain and movement limitations of individuals after surgery and to increase their activity and participation levels. It is stated that postoperative rehabilitation programs should especially include stabilization, proprioception, and postural balance training. Postoperative rehabilitation a...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Having been diagnosed with Adolescent Idiopathic Scoliosis by an orthopedic specialist
- • Being between the ages of 10 and 18
- • The Cobb angle determined on the anteroposterior radiograph must be over 45 degrees before surgery.
- • Having had posterior spinal fusion surgery
- • Between 8th week and 6 months postoperatively
- • Ability to understand and follow instructions
- • Volunteering to participate in the study
- Exclusion Criteria:
- • Complications that prevent rehabilitation after surgery (such as postoperative cerebrospinal fluid leak, paraparesis, hemiparesis)
- • Neuromuscular, rheumatic disease or vestibular problems that may affect balance, vision-related diseases
- • Orthopedic problems that may prevent participation in the exercise program
- • Serious lung complications associated with surgery
- • Any other exercise or physical activity that may affect trunk muscle strength or balance
- • Patients who cannot understand and follow instructions
About Istanbul University Cerrahpasa
Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Trial Officials
Ayse Zengin Alpozgen, Assoc. Prof.
Principal Investigator
Istanbul University - Cerrahpasa
Turgut Akgül, Prof.
Study Chair
Istanbul University
Elçin Akyurek, Msc
Principal Investigator
Istanbul University - Cerrahpasa
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported